Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Ruben P.A. van Eijk"'
Autor:
Jordi W.J. van Unnik, Myrte Meyjes, Mark R. Janse van Mantgem, Leonard H. van den Berg, Ruben P.A. van Eijk
Publikováno v:
EBioMedicine, Vol 103, Iss , Pp 105104- (2024)
Summary: Background: There is an urgent need for objective and sensitive measures to quantify clinical disease progression and gauge the response to treatment in clinical trials for amyotrophic lateral sclerosis (ALS). Here, we evaluate the ability o
Externí odkaz:
https://doaj.org/article/43b2c3e735714a7d9e5414f6593831ac
Autor:
Mark R. Janse van Mantgem, Wouter van Rheenen, Anemone V. Hackeng, Michael A. van Es, Jan H. Veldink, Leonard H. van den Berg, Ruben P.A. van Eijk
Publikováno v:
Neurology. 100:e1062-e1071
To explore the association between lipids, polygenic profile scores (PPS) for biomarkers of lipid metabolism, markers of disease severity, and survival in patients with Amyotrophic Lateral Sclerosis (ALS).We meta-analyzed the current literature on th
Publikováno v:
Journal of Clinical Epidemiology, 147, pp. 32-39
J Clin Epidemiol
Journal of Clinical Epidemiology, 147, 32-39
J Clin Epidemiol
Journal of Clinical Epidemiology, 147, 32-39
OBJECTIVE: Correlated longitudinal and time-to-event outcomes, such as the rate of cognitive decline and the onset of Alzheimer’s disease, are frequent (co-)primary and key secondary endpoints in randomized clinical trials (RCTs). Despite their bio
Autor:
Tessa Kliest, Ruben P.A. Van Eijk, Ammar Al-Chalabi, Alberto Albanese, Peter M. Andersen, Maria Del Mar Amador, Geir BrÅthen, Veronique Brunaud-Danel, Lev Brylev, William Camu, Mamede De Carvalho, Cristina Cereda, Hakan Cetin, Delia Chaverri, Adriano Chiò, Philippe Corcia, Philippe Couratier, Fabiola De Marchi, Claude Desnuelle, Michael A. Van Es, JesÚs Esteban, Massimiliano Filosto, Alberto GarcÍa Redondo, Julian Grosskreutz, Clemens O. Hanemann, Trygve HolmØy, Helle HØyer, Caroline Ingre, Blaz Koritnik, Magdalena Kuzma-Kozakiewicz, Thomas Lambert, Peter N. Leigh, Christian Lunetta, Jessica Mandrioli, Christopher J. Mcdermott, Thomas Meyer, Jesus S. Mora, Susanne Petri, MÓnica Povedano, Evy Reviers, Nilo Riva, Kit C.B. Roes, Miguel Á. Rubio, FranÇois Salachas, Stayko Sarafov, Gianni SorarÙ, Zorica Stevic, Kirsten Svenstrup, Anette Torvin MØller, Martin R. Turner, Philip Van Damme, Lucie A.G. Van Leeuwen, Luis Varona, Juan F. VÁzquez Costa, Markus Weber, Orla Hardiman, Leonard H. Van Den Berg
Publikováno v:
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 2022, pp.1-8. ⟨10.1080/21678421.2021.2024856⟩
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 23, 481-488
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 23, 7-8, pp. 481-488
Kliest, T, Van Eijk, R P A, Al-Chalabi, A, Albanese, A, Andersen, P M, Amador, M D M, BrÅthen, G, Brunaud-Danel, V, Brylev, L, Camu, W, De Carvalho, M, Cereda, C, Cetin, H, Chaverri, D, Chiò, A, Corcia, P, Couratier, P, De Marchi, F, Desnuelle, C, Van Es, M A, Esteban, J, Filosto, M, GarcÍa Redondo, A, Grosskreutz, J, Hanemann, C O, HolmØy, T, HØyer, H, Ingre, C, Koritnik, B, Kuzma-Kozakiewicz, M, Lambert, T, Leigh, P N, Lunetta, C, Mandrioli, J, Mcdermott, C J, Meyer, T, Mora, J S, Petri, S, Povedano, MÓ, Reviers, E, Riva, N, Roes, K C B, Rubio, M, Salachas, F, Sarafov, S, SorarÙ, G, Stevic, Z, Svenstrup, K, MØller, A T, Turner, M R, Van Damme, P, Van Leeuwen, L A G, Varona, L, VÁzquez Costa, J F, Weber, M, Hardiman, O & Van Den Berg, L H 2022, ' Clinical trials in pediatric ALS : a TRICALS feasibility study ', Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, vol. 23, no. 7-8, pp. 481-488 . https://doi.org/10.1080/21678421.2021.2024856
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 2022, pp.1-8. ⟨10.1080/21678421.2021.2024856⟩
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 23, 481-488
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 23, 7-8, pp. 481-488
Kliest, T, Van Eijk, R P A, Al-Chalabi, A, Albanese, A, Andersen, P M, Amador, M D M, BrÅthen, G, Brunaud-Danel, V, Brylev, L, Camu, W, De Carvalho, M, Cereda, C, Cetin, H, Chaverri, D, Chiò, A, Corcia, P, Couratier, P, De Marchi, F, Desnuelle, C, Van Es, M A, Esteban, J, Filosto, M, GarcÍa Redondo, A, Grosskreutz, J, Hanemann, C O, HolmØy, T, HØyer, H, Ingre, C, Koritnik, B, Kuzma-Kozakiewicz, M, Lambert, T, Leigh, P N, Lunetta, C, Mandrioli, J, Mcdermott, C J, Meyer, T, Mora, J S, Petri, S, Povedano, MÓ, Reviers, E, Riva, N, Roes, K C B, Rubio, M, Salachas, F, Sarafov, S, SorarÙ, G, Stevic, Z, Svenstrup, K, MØller, A T, Turner, M R, Van Damme, P, Van Leeuwen, L A G, Varona, L, VÁzquez Costa, J F, Weber, M, Hardiman, O & Van Den Berg, L H 2022, ' Clinical trials in pediatric ALS : a TRICALS feasibility study ', Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, vol. 23, no. 7-8, pp. 481-488 . https://doi.org/10.1080/21678421.2021.2024856
Background: Pediatric investigation plans (PIPs) describe how adult drugs can be studied in children. In 2015, PIPs for Amyotrophic Lateral Sclerosis (ALS) became mandatory for European marketing-authorization of adult treatments, unless a waiver is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::31fe6c6cded34ce9af67049e3ef23c06
https://hal-unilim.archives-ouvertes.fr/hal-03673852
https://hal-unilim.archives-ouvertes.fr/hal-03673852